The involvement of mast cells in the irinotecan-induced enteric neurons loss and reactive gliosis-Reference-Cited by-同舟云学术

The involvement of mast cells in the irinotecan-induced enteric neurons loss and reactive gliosis

Published:2017-04-07 Issue:1 Volume:14 Page:
ISSN:1742-2094
Container-title:Journal of Neuroinflammation
language:en
Short-container-title:J Neuroinflammation

Author:

Nogueira Ludmila T.,Costa Deiziane V. S.,Gomes Antoniella S.,Martins Conceição S.,Silva Angeline M. H. P.,Coelho-Aguiar Juliana M.,Castelucci Patrícia,Lima-Júnior Roberto C. P.,Leitão Renata F. C.,Moura-Neto Vivaldo,Brito Gerly A. C.

Funder

CAPES/DINTER

CAPES/Procad

Publisher

Springer Science and Business Media LLC

Subject

Cellular and Molecular Neuroscience,Neurology,Immunology,General Neuroscience

Link

http://link.springer.com/content/pdf/10.1186/s12974-017-0854-1.pdf

Reference50 articles.

1. Ramesh M, Ahlawat P, Srinivas NR. Irinotecan and its active metabolite, SN-38: review of bioanalytical methods and recent update from clinical pharmacology perspectives. Biomed Chromatogr. 2010;24:104–23.

2. Lee CS, Ryan EJ, Doherty GA. Gastro-intestinal toxicity of chemotherapeutics in colorectal cancer: the role of inflammation. World J Gastroenterol. 2014;20:3751–61.

3. Keefe DM. Intestinal mucositis. mechanisms and management. Curr Opin Oncol. 2007;19:323–7.

4. Peterson DE, Bensadoun RJ, Roila F, Group EGW. Management of oral and gastrointestinal mucositis: ESMO Clinical Practice Guidelines. Ann Oncol. 2011;22 Suppl 6:vi78–84.

5. Elting LS, Cooksley C, Chambers M, Cantor SB, Manzullo E, Rubenstein EB. The burdens of cancer therapy. Clinical and economic outcomes of chemotherapy-induced mucositis. Cancer. 2003;98:1531–9.

Cited by 29 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Clostridioides difficile infection promotes gastrointestinal dysfunction in human and mice post-acute phase of the disease;Anaerobe;2024-06

2. Enteric Nervous System Alterations in Inflammatory Bowel Disease: Perspectives and Implications;Gastrointestinal Disorders;2024-03-28

3. Restoring Colon Motility in Parkinson's Disease: GDNF-Mediated CX43 Suppression in Reactive Enteric Glial Cells;2024-02-02

4. From the Gut to the Brain: The Role of Enteric Glial Cells and Their Involvement in the Pathogenesis of Parkinson’s Disease;International Journal of Molecular Sciences;2024-01-20

5. Involvement of iNOS-induced reactive enteric glia cells in gastrointestinal motility disorders of postoperative Ileus mice;Journal of Chemical Neuroanatomy;2023-11